Phase III Study of F-18-PSMA-1007 vs F-18-Fluorocholine PET to Compare the Detection Rate of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluorine-18 PSMA 1007 (Primary) ; Fluorocholine 18F
Indications Carcinoma; Prostate cancer
Focus Diagnostic use; Registrational
Sponsors Advanced Biochemical Compounds (ABX GmbH)

Most Recent Events

28 Jun 2021 Status changed from active, no longer recruiting to completed.
03 Feb 2021 Planned End Date changed from 1 Sep 2020 to 1 Mar 2021.
27 Aug 2020 Planned End Date changed from 1 Jun 2020 to 1 Sep 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight